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Control of Pre-BCR Signaling
by Pax5-Dependent Activation of the BLNK Gene
immunoreceptor tyrosine-based activation motifs (ITAMs)
of either the Ig or Ig chain are required for pre-BCR
function, as their phosphorylation upon pre-BCR as-
Michael Schebesta, Peter L. Pfeffer,2
and Meinrad Busslinger1
Research Institute of Molecular Pathology
sembly provides docking sites for the tandem SH2 do-Vienna Biocenter
mains of the Syk tyrosine kinase (Papavasiliou et al.,Dr. Bohr-Gasse 7
1995). B cell development in Syk-deficient mice is ar-A-1030 Vienna
rested prior to the pre-B cell stage, thus revealing aAustria
critical role of Syk in pre-BCR signaling (Cheng et al.,
1995; Turner et al., 1995). A key substrate of the Syk
kinase is the adaptor protein BLNK (SLP-65,BASH; FuSummary
et al., 1998; Wienands et al., 1998; Goitsuka et al., 1998).
Upon interaction with Syk, BLNK becomes rapidly phos-The developmental progression from pro-B to pre-B
phorylated on multiple N-terminal tyrosine residues,cells is controlled by pre-B cell receptor (pre-BCR)
which act as binding sites to recruit the SH2 domain-signaling which depends on BLNK (SLP-65) for cou-
containing proteins PLC2, Btk, Vav, Grb2, and Nckpling the Syk kinase to its downstream effector path-
into the signaling complex (reviewed by Kurosaki andways. Here we identified BLNK as a direct target of
Tsukada, 2000). Although some of these proteins havethe transcription factor Pax5 (BSAP). Restoration of
also been identified in the lipid raft-associated signalo-BLNK expression in Ig transgenic Pax5/ pro-B cells
some of the pre-BCR (Guo et al., 2000), the downstreamresulted in constitutive pre-BCR signaling and in-
signaling events have mainly been elucidated for thecreased cell proliferation without inducing progres-
BCR. Phosphorylation of the recruited effector proteinssion to the pre-B cell stage. Ig Pax5/ pro-B cells
by Syk leads to activation of intracellular calcium signal-expressing a BLNK-estrogen receptor fusion protein
ing, protein kinase C, and different MAPK pathways (Fuinitiated signaling immediately upon hormone addi-
et al., 1998; Ishiai et al., 1999). BLNK therefore acts astion, which facilitated analysis of pre-BCR-induced
a molecular scaffold to link the (pre)BCR-activated Sykgene expression changes. The pre-BCR was shown
kinase to regulators of multiple downstream signalingto execute its checkpoint function by regulating genes
pathways. In agreement with a central role in pre-BCRinvolved in cell proliferation, intracellular signaling,
signaling, BLNK gene mutations arrest B cell develop-growth factor responsiveness, and V(D)J recombi-
ment at the pro-B to pre-B cell transition in humansnation.
(Minegishi et al., 1999) and mice (Jumaa et al., 1999;
Pappu et al., 1999; Hayashi et al., 2000; Xu et al., 2000).Introduction
BLNK is expressed in B-lymphocytes and macrophages
(Fu et al., 1998; Wienands et al., 1998; Bonilla et al.,
Productive rearrangement of the immunoglobulin
2000), although nothing is yet known about the lineage-
heavy-chain (IgH) gene leads to assembly of the pre-
specific regulation of this gene.
B cell receptor (pre-BCR), which acts as an important The transcription factor Pax5 (BSAP) controls B cell
checkpoint in early B-lymphopoiesis by controlling the commitment by activating the expression of B-lym-
transition from the pro-B to the pre-B cell stage. Signal- phoid-specific genes and simultaneously repressing the
ing from the pre-BCR promotes allelic exclusion at the transcription of lineage-inappropriate genes (Nutt et al.,
IgH locus, stimulates proliferative cell expansion, and 1999). Pax5 inactivation arrests B cell development at
induces differentiation to small pre-B cells, which un- the stage of early pro-B (pre-BI) cells, which fail to as-
dergo rearrangement of the immunoglobulin light-chain semble the pre-BCR due to an 50-fold reduction of
genes. In addition to Ig, the pre-BCR complex is com- VH-DHJH recombination at the IgH locus (Nutt et al., 1997).
posed of the surrogate light chains 5 and VpreB as Complementation of this deficiency by expression of
well as of the signal-transducing proteins Ig and Ig. a rearranged Ig transgene was, however, unable to
All five components contribute to the function of the advance B cell development to the small pre-B (pre-
pre-BCR, as mutation of their genes results in the loss BII) cell stage in Pax5/ mice (The´venin et al., 1998).
of pre-BCR expression and arrest of B cell development Expression of the pre-BCR on Ig Pax5/ pro-B cells
at the pro-B cell stage (reviewed by Rajewsky, 1996). failed to elicit signaling, suggesting that Pax5 controls
Cell surface expression of the pre-BCR appears to be the transcription of an essential signal-transducing mol-
sufficient to activate signaling in the absence of a ligand, ecule (The´venin et al., 1998).
which is contrasted by the ligand dependency of the Here we demonstrate that Pax5 regulates the BLNK
BCR on B cells (Shaffer and Schlissel, 1997; Rolink et gene by binding to its proximal promoter region. Resto-
al., 2000). Contrary to the BCR, the signaling events ration of BLNK expression in Ig Pax5/ pro-B cells
downstream of the pre-BCR are poorly understood and rescued the proliferative function of the pre-BCR and
have mainly been investigated by genetic studies. The facilitated a systematic analysis of the gene expression
changes initiated by pre-BCR signaling. These microar-
ray data demonstrated that the pre-BCR executes its1Correspondence: busslinger@nt.imp.univie.ac.at
checkpoint function in early B-lymphopoiesis by regulat-2 Present address: AgResearch, Crown Research Institute, Private
Bag 3123, Hamilton, New Zealand. ing diverse processes including cell proliferation, intra-
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Figure 1. Identification of BLNK as a Direct Pax5 Target
(A) Western blot analysis of in vitro-cultured wild-type (/) and Pax5 mutant (/) pro-B cells with anti-BLNK and anti-Pax5 antibodies.
(B) Quantitation of BLNK and control S16 mRNA by RNase protection assay.
(C) Direct activation of BLNK by Pax5-ER. Pax5/ pro-B cells expressing the Pax5-ER protein (KO-Pax5-ER cells) were treated for 12 hr with
-estradiol (E2, 1 M) or 4-hydroxytamoxifen (OHT, 1 M) prior to RNase protection analysis. KO-Pax5-ER cells were additionally incubated
for 8 hr with cycloheximide (CHX, 50 g/ml), and E2 was added during the last 4 hr of CHX treatment.
(D) Transcription start sites. Pro-B cell RNA was analyzed by S1 nuclease protection with a DNA probe that was 5 end-labeled in BLNK exon
1. (GA), same probe cleaved at purines.
(E) Initiation region of mouse and human BLNK genes. Dots denote gaps in the alignment. The transcription start sites (arrows) are shown
together with the DNase I footprints of Pax5 (black bars).
cellular signaling, growth factor responsiveness, and Importantly, the BLNK gene was activated by estrogen
even in the presence of the protein synthesis inhibitorV(D)J recombination.
cycloheximide (CHX), demonstrating that BLNK is a di-
rect target of Pax5 (Figure 1C). The BLNK gene wasResults
furthermore shown to be transcribed from different start
sites (Figures 1D and 1E). Hence, the transcription ofDirect Activation of the BLNK Gene by Pax5
BLNK is heterogeneously initiated and entirely dependsTo identify novel Pax5 target genes, we took advantage
on Pax5 function similar to the previously characterizedof a posttranslational induction system based on the
target gene CD19 (Kozmik et al., 1992; Nutt et al., 1998).hormone-inducible Pax5-estrogen receptor (ER) fusion
protein (Nutt et al., 1998). Pax5/ pro-B cells expressing
the Pax5-ER protein (KO-Pax5-ER cells) were stimulated Pax5 Activates BLNK by Binding to the Transcription
Initiation Regionwith estrogen for 12 hr, and Pax5-induced transcripts
were enriched by cDNA subtraction, which resulted in DNase I footprint analyses revealed that Pax5 interacts
with two sites in the proximal promoter of the mousethe isolation of several BLNK cDNA clones. RNase pro-
tection and Western blot analyses demonstrated that and human BLNK genes (Figures 2A and 2B). Site 1 is
located immediately upstream of the most distal tran-the BLNK mRNA and protein were undetectable in
Pax5/ pro-B cells in contrast to wild-type pro-B cells scription start sequence (Figures 1E and 2G) and binds
Pax5 with similar efficiency as the high-affinity binding(Figures 1A and 1B). Moreover, BLNK transcription was
rapidly induced in KO-Pax5-ER cells by treatment with site of CD19 (Figure 2D). Site 2 maps to the proximal
cluster of initiation sequences and corresponds to a low-estrogen (E2) or 4-hydroxy-tamoxifen (OHT; Figure 1C).
Pax5-Dependent Function of the Pre-BCR
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Figure 2. Pax5 Binding to the BLNK Promoter
(A–C) DNase I footprint analysis. 5 end-labeled DNA fragments containing the mouse (A and C) or human (B) BLNK promoter were incubated
with increasing amounts of purified Pax5 protein (A and B) or with nuclear extracts (C) prepared from pre-B (PD31), B (BJA-B), macrophage
(WEHI-3), and epithelial (HeLa) cell lines prior to DNase I digestion. (GA), probe cleaved at purines; (), naked DNA; u, ubiquitous; m,
macrophage-specific footprint.
(D) EMSA analysis. The binding of recombinant Pax5 to the two sites of mouse BLNK was compared to the high-affinity site of the CD19
promoter (Kozmik et al., 1992). A 100-fold excess of unlabeled CD19 oligonucleotide was used as competitor DNA (comp.).
(E) Methylation interference analysis with purified Pax5 protein and site 1 or 2 probes. F and B denote free and bound DNA, respectively.
Black arrowheads point to methylated G residues interfering with Pax5 binding and open arrowheads to methylated G residues enhancing
protein binding.
(F) Transient transfection assay. Luciferase genes carrying a wild-type (WT) or mutant (M) BLNK promoter (510 bp upstream of start codon)
were transfected with the control vector pRL-SV40 into the B cell line BJA-B. After 48 hr, luciferase activities were measured, normalized,
and displayed relative to the activity of the parental vector pGL3. The mutations GGACACCATGGCC (M1) and ACT
CCAATTGA (M2) were introduced into sites 1 and 2, respectively.
(G) Sequence alignment of the two BLNK sites with the Pax5 consensus recognition sequence (Czerny and Busslinger, 1995). The DNase I
footprints (brackets), methylation interference data (arrowheads), major start sites (arrows), and consensus nucleotides (black overlay) are
shown.
affinity binding site (Figures 2A and 2D). Accordingly, sites match the consensus sequence at 10 out of 15
positions, only site 1 contains the most conserved GCGthe high-affinity site 1 was fully protected by nuclear
extracts of the B-lymphoid cell lines PD31 and BJA-B motif, thus explaining its higher binding affinity. A lucifer-
ase reporter gene under the control of the mouse BLNKin contrast to the variable occupancy of site 2 in these
extracts (Figure 2C). A macrophage-specific footprint, promoter was activated 4-fold by endogenous Pax5 in
transiently transfected B cells (WT; Figure 2F). This pro-detected in WEHI-3 extracts, was mapped between the
two Pax5 binding sites, whereas two upstream promoter moter activity was reduced by mutation of site 1 (M1)
or 2 (M2) and was lost upon inactivation of both sitesregions were bound by nuclear factors present in all
extracts (Figure 2C). Hence, the proximal promoter of (M1/2; Figure 2F). Hence, Pax5 activates BLNK by bind-
ing to its transcription initiation region.BLNK interacts with the B-cell-specific transcription fac-
tor Pax5 as well as with macrophage-specific and ubiq-
uitous proteins, which have not been further charac- BLNK Expression Fails to Advance B Cell
Development in Pax5/ Miceterized.
The Pax5 contact sites within the BLNK promoter were The pre-BCR was shown to be stably maintained on
Pax5/ pro-B cells expressing a rearranged Ig trans-mapped by methylation interference to facilitate their
alignment with the Pax5 consensus recognition se- gene (M54), but yet it failed to signal and thus promote




We next crossed the functional IkBLNK transgene into Ig
Pax5/ mice to investigate whether it could also pro-
mote differentiation from the pro-B cell to the pre-B cell
stage in these mice. This developmental transition is
characterized by the downregulation of c-Kit and CD43
and concomitant expression of CD2 and CD25 (Ro-
link et al., 1994). Control Pax5/ mice carrying the Ig
and IkBLNK transgenes predominantly contained CD2
CD25B220 pre-B cells in the bone marrow (Figure
3B), consistent with the fact that expression of a re-
arranged Ig transgene shortens pro-B cell develop-
ment by inducing pre-B cell differentiation (The´venin et
al., 1998). Pre-B cells were, however, absent in the bone
marrow of Ig Pax5/ mice, which gave rise only to
c-KitCD43B220 pro-B cells even in the presence of
the IkBLNK transgene (Figure 3B). All pro-B cells of the
double transgenic Pax5/ mice were GFP and ex-
pressed reduced levels of c-Kit compared to Ig
Pax5/ pro-B cells (Figures 3B and 3C). The BLNK-
reconstituted Pax5/ pro-B cells could efficiently mobi-
lize intracellular calcium upon stimulation with an anti-
antibody, indicating that the IkBLNK transgene restored
BLNK function also in Pax5/ mice (Figure 5E). Never-
theless, the restoration of BLNK function in Ig
Pax5/mice was not sufficient to promote develop-
mental progression to the pre-B cell stage, which addi-
tionally depends on Pax5 functions other than BLNK
activation.
BLNK Restores Pre-BCR Signaling in Reconstituted
Pax5/ Pro-B Cells
To investigate whether BLNK expression restores pre-
BCR signaling in Pax5/ pro-B cells, we infected in vitro
cultured pro-B cells with a BLNK retrovirus (Figure 4A)
and analyzed c-Kit and pre-BCR expression on the sur-
face of infected GFP and uninfected GFP cells (Fig-
ures 4B and 4C). The expression of c-Kit remained unal-
tered in Ig Pax5/ pro-B cells that were infected with
the Mig-BLNK virus (Figure 4C). Likewise, infection of
Ig Pax5/ pro-B cells with the parental virus MigR1
did not affect expression of c-Kit or the pre-BCR. In
contrast, expression of both the pre-BCR and c-Kit
was downregulated on BLNK (GFP)-expressing IgFigure 3. BLNK Transgene Expression Fails to Advance B Cell De-
Pax5/ pro-B cells (Figure 4C) in agreement with thevelopment in Pax5/ Mice
fact that signaling leads to internalization of the pre-(A) IkBLNK transgene. The mouse BLNK cDNA linked via IRES to a
BCR and loss of c-Kit expression (Rolink et al., 1994;GFP gene was inserted into exon 1 of an Ikaros BAC. nc, noncoding.
Winkler et al., 1995; Salamero et al., 1995). These results(B) Flow cytometric analysis. Bone marrow cells from 2-week-old
Ig transgenic mice of the indicated genotypes were analyzed for were independently confirmed by expression of a BLNK-
the expression of pro-B (c-Kit, CD43) and pre-B (CD2, CD25) cell GFP fusion protein in Ig Pax5/ pro-B cells, which
markers. also resulted in efficient c-Kit downregulation (Figure
(C) GFP and c-Kit expression in B220 cells of the indicated geno-
5B). Fluorescence microscopy furthermore revealed antypes.
inverse correlation between the expression of BLNK-
GFP and the cell surface location of the pre-BCR (Figure
5C). Hence, BLNK expression was able to restore pre-(The´venin et al., 1998). Having identified BLNK as a Pax5
BCR signaling in Ig Pax5/ pro-B cells.target gene, we tested the hypothesis that the absence
of this adaptor molecule may be responsible for the pre-
BCR signaling defect in Pax5/ mice. We thus brought Pre-BCR Signaling Stimulates Proliferation
of Reconstituted Pax5/ Pro-B Cellsa BLNK minigene under the control of the Ikaros locus
by insertion into an Ikaros bacterial artificial chromo- Pro-B cells depend on proliferative signals from the c-Kit
receptor, which is activated by ligands expressed onsome (Ik BAC; Figure 3A). This IkBLNK transgene com-
pletely rescued the B cell developmental defect of stromal cells (Rolink et al., 1991). As pre-BCR signaling
initiates a radical change in growth factor requirementsBLNK/ mice (see Supplemental Figure S1 at http://
Pax5-Dependent Function of the Pre-BCR
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Figure 4. Increased Proliferation of BLNK-Reconstituted Ig Pax5/ Pro-B Cells
(A) Retroviral vectors. The mouse BLNK cDNA was inserted into the retroviral vector MigR1 (Pear et al., 1998).
(B and C) Flow cytometric analysis. Nontransgenic () or Ig transgenic Pax5/ pro-B cells were infected with the indicated retrovirus and
cultured for 1 week prior to analysis of pre-BCR and c-Kit expression on noninfected GFP (black) and infected GFP (green) cells. The pre-
BCR was detected with the SL156 antibody recognizing a conformational epitope on the surrogate light chain-Ig complex (Winkler et al.,
1995).
(D and E) Proliferation of reconstituted Pax5/ pro-B cells. Infected pro-B cells of the indicated genotypes were cultured in IL-7 medium after
the withdrawal of stromal ST2 cells at day 0. The percentage of GFP pro-B cells was measured by flow cytometry during the next 12 days
as shown for the BLNK-expressing Ig Pax5/ pro-B cells (D). The relative (E) and absolute (D) increases of GFP cells are shown.
(F) Rescue of pre-B cell differentiation by Pax5. GFP expression of Ig Pax5/ pro-B cells was determined 3 days and 2 months after
infection with the Mig-Pax5 virus. Pro-B cells expressing a specific GFP (Pax5) level (arrow) were lost, as they differentiated to pre-B cells.
(Rajewsky, 1996), we cultured BLNK-reconstituted Ig (see Supplementary Figure S2 http://www.immunity.
org/cgi/content/full/17/4/473/DC1). As pre-B cells arePax5/ pro-B cells in the absence of stromal ST2 cells to
study their proliferative response to pre-BCR signaling. unresponsive to pro-B cell growth stimuli and therefore
cannot be propagated under our in vitro culture condi-Under these conditions, the BLNK-expressing GFP
cells rapidly outgrew the uninfected GFP cells within tions (The´venin et al., 1998), they were lost within 2
months of in vitro culture (Figure 4F). We conclude there-12 days (Figure 4D). The proliferative advantage of the
reconstituted pro-B cells was strictly dependent on the fore that differentiation to pre-B cells was only rescued
in a subset of pro-B cells where Pax5 expression wasexpression of both the pre-BCR and BLNK, as it was
not observed with GFP cells either lacking the Ig restored to wild-type levels. A similar cell loss was never
observed with BLNK-reconstituted Ig Pax5/ pro-Btransgene or expressing the parental MigR1 virus (Figure
4E). Hence, BLNK expression restores the proliferative cells, indicating that the restoration of BLNK expression
also failed to rescue the differentiation block in vitro.function of the pre-BCR in Ig Pax5/ pro-B cells.
Retroviral Pax5 expression in Ig Pax5/ pro-B cells
led to the same increase in proliferation as in BLNK- PLC2 Activation and Calcium Signaling
in Reconstituted Pax5/ Pro-B Cellsreconstituted pro-B cells (Figure 4E). Three days after
infection with the Mig-Pax5 retrovirus, the Ig Pax5/ The Syk kinase phosphorylates BLNK and thus activates
its adaptor function in response to BCR stimulation inpro-B cells displayed a broad range of GFP expression
levels, although only a specific subset of these pro-B mature B cells (Fu et al., 1998). Here we could demon-
strate that Syk is also the upstream kinase of BLNK incells activated expression of the pre-B cell marker CD2
Immunity
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Figure 5. Calcium Signaling in Reconstituted Pax5/ Pro-B Cells
(A) Syk dependency of BLNK function. BLNK-expressing Ig Pax5/ pro-B cells were incubated for 4 days with or without the Syk/Zap-70-
specific inhibitor YA6/22 (5 M) prior to flow cytometric analysis. The systematic name of YA6/22 is 2-(2-amino-ethylamino)-4-(3-ethyl-
phenylamino)-pyrimidine-5-carboxylic acid amide (Yamanouchi, 1999).
(B) c-Kit downregulation on Ig Pax5/ pro-B cells infected with the Mig-BLNK-GFP retrovirus (green).
(C) Inverse correlation between BLNK-GFP and pre-BCR expression. Ig Pax5/ pro-B cells infected with the BLNK-GFP virus were stained
with biotinylated SL156 antibody (revealed by Alexa546-streptavidin) prior to fluorescence microscopy.
(D) Flow cytometric analysis of calcium fluxes. Ig Pax5/ pro-B cells expressing BLNK, BLNK-GFP, or GFP (MigR1) were stimulated by
the addition of anti- antibody (arrow). Intracellular calcium changes were recorded as the fluorescence 405/485 nm ratio of Indo-1 emission.
The inhibitor YA6/22 (5 M) was added 4 days prior to analysis.
(E) Calcium mobilization in vivo. Bone marrow cells from 2-week-old IkBLNK Pax5/ mice, with or without the Ig transgene, were analyzed as
described above, and the calcium fluxes of B220 cells are displayed.
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pre-BCR signaling, as the Syk/Zap-70-specific inhibitor expressing pro-B cells, which rapidly differentiate to
small pre-B cells that no longer express the receptorYA6/22 (Yamanouchi, 1999) efficiently blocked the dow-
nregulation of c-Kit expression in BLNK-reconstituted (Rajewsky, 1996). In contrast to the wild-type situation,
the pre-BCR is locked into a continuous signaling modeIg Pax5/ pro-B cells (Figure 5A). Activated BLNK
in turn couples the Syk kinase to phospholipase C2 in BLNK-reconstituted Ig Pax5/ pro-B cells due to
the developmental block of the Pax5 mutation. We next(PLC2), which generates, by hydrolysis of phosphati-
dylinositols, the second messenger inositol 1,4,5-tris- generated an inducible pre-BCR signaling system by
fusing BLNK at its C terminus to the ligand bindingphosphate (IP3), leading to an increase in intracellular
calcium and activation of nuclear transcription factors domain of a mutant estrogen receptor (ERT2; Feil et al.,
1997). The BLNK-ERT2 fusion protein was inactive in the(Ishiai et al., 1999). To investigate calcium signaling in
reconstituted Ig Pax5/ pro-B cells, we stimulated absence of hormone but could be rapidly induced by
the synthetic ligand OHT in Ig Pax5/ pro-B cellsthe pre-BCR with an anti- antibody and monitored the
intracellular calcium changes by flow cytometry (Figure (Figure 6A). These BLNK-ERT2-expressing cells down-
regulated c-Kit already 6 hr after OHT treatment, which5D). In contrast to GFP, both BLNK and BLNK-GFP facili-
tated rapid and transient calcium mobilization in Ig was followed by a decrease in pre-BCR and CD43 ex-
pression (Figure 6A). OHT-dependent activation ofPax5/ pro-B cells. Moreover, these calcium fluxes were
Syk dependent, as they were abolished by the inhibitor BLNK-ERT2 alone was already sufficient to trigger a rapid
and sustained calcium response, which did not requireYA6/22 (Figure 5D).
Immunoprecipitation of BLNK, Syk, and PLC2 re- artificial stimulation of the pre-BCR with anti- antibod-
ies (Figure 6B). As a consequence, the nuclear factorsvealed only a low level of BLNK protein in reconstituted
Ig Pax5/ pro-B cells in contrast to BLNK-GFP and NF-	B and AP-1 were activated within 1 hr of OHT treat-
ment (Figure 6C), and the proliferation rate was in-the high BLNK expression of wild-type pro-B cells (Fig-
ure 5G). All three pro-B cell types expressed, however, creased, as the BLNK-ERT2-expressing pro-B cells rap-
idly outgrew the ERT2-expressing control cells (Figuresimilar levels of the respective BLNK transcript, indicat-
ing that the discrepancy in protein expression must arise 6D). Since the hormone binding domain of the estrogen
receptor can potentially interact with the Src/Shc/ERK-posttranscriptionally. The in vitro propagation of wild-
type pro-B cells is known to select against expression signaling pathway (Kousteni et al., 2001), it was impor-
tant to control the specificity of BLNK-ERT2 induction byof the pre-BCR (The´venin et al., 1998). Indeed, 
4% of
the wild-type pro-B cells were pre-BCR, which resulted analyzing ERT2-expressing cells in these and all subse-
quent experiments. In conclusion, the posttranslationalin tyrosine phosphorylation of only a minor fraction of
BLNK and the downstream PLC2 protein (Figures 5G BLNK-ERT2 induction system offers the unique opportu-
nity to study gene expression changes in response toand 5I). In contrast, the BLNK-GFP protein was effi-
ciently phosphorylated in reconstituted Ig Pax5/ conditional activation of pre-BCR signaling.
pro-B cells, which correlated with increased phosphory-
lation of the upstream Syk kinase and downstream ef- Gene Expression Changes in Response
to Pre-BCR Signalingfector PLC2 (Figures 5H and 5I). Although the small
amount of BLNK protein present in reconstituted Ig We first analyzed the expression of candidate genes in
BLNK-ERT2-reconstituted Ig Pax5/ pro-B cells (Fig-Pax5/ pro-B cells was also phosphorylated (detected
on long exposures), it did not lead to increased PLC2 ures 7A and 7D). The transcription of RAG1, RAG2, and
TdT was repressed already at 6 hr after OHT additionphosphorylation but instead resulted in decreased lev-
els of phosphorylated Syk (Figures 5H and 5I). The low in agreement with published data demonstrating that
these genes are downregulated at the pro-B to pre-Bconcentration of phosphorylated BLNK, Syk, and PLC2
in BLNK-reconstituted Ig Pax5/ pro-B cells is best cell transition (Li et al., 1993; Grawunder et al., 1995).
In contrast, the expression of the pre-BCR componentsexplained by the fact that these cells are locked into a
persistent and asynchronous signaling mode due to Ig, 5, and VpreB1 was only weakly repressed (Figure
7A), suggesting that internalization of the pre-BCR istheir differentiation arrest. Newly synthesized BLNK pro-
tein continuously initiated a cycle of signaling, internal- primarily responsible for its decreased expression on
reconstituted Ig Pax5/ pro-B cells. Surprisingly, theization, and degradation of the pre-BCR signalosome.
In contrast, this degradation appeared to be partially transcription of c-kit remained unaffected by pre-BCR
signaling, thus implicating posttranslational mecha-blocked by the C-terminal GFP extension of BLNK,
which resulted in the accumulation of signaling com- nisms in the rapid loss of c-Kit expression from the cell
surface.plexes in BLNK-GFP-expressing cells.
A systematic analysis of the gene expression changes
in response to BLNK-ERT2 activation was performed byInducible Pre-BCR Signaling in BLNK-ERT2-
Expressing Cells screening a microarray of 17,000 ESTs. Figure 7B pre-
sents the expression data of 90 ESTs that fulfilled theAny molecular analysis of pre-BCR signaling is compli-
cated by the transient nature of the pre-BCR on Ig- following criteria: (1) reproducible expression changes
(F) RNase protection analysis of BLNK and control S16 mRNA in cultured wild-type (/) and infected Ig Pax5/ pro-B cells.
(G–I) Protein phosphorylation. Serum-starved pro-B cells were stimulated for 2 min with pervanadate and anti- antibody prior to precipitation
of BLNK, Syk, and PLC2 from whole-cell lysates. Precipitates were immunoblotted with an anti-phosphotyrosine (pY) antibody and reprobed
with a protein-specific antibody. Arrowheads denote the different BLNK proteins, and asterisks indicate unknown phosphotyrosine proteins.
Immunity
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Figure 6. Inducible Pre-BCR Signaling
System
(A) Receptor expression. Ig Pax5/ pro-B
cells infected with the Mig-BLNK-ERT2 virus
were treated with OHT (1 M) for the indi-
cated time, and the expression of c-Kit, CD43,
and the pre-BCR was displayed for infected
GFP (green) and noninfected GFP (black)
cells.
(B) Calcium mobilization. The addition of OHT
rapidly induced calcium fluxes in Mig-BLNK-
ERT2-infected Ig Pax5/ pro-B cells in con-
trast to Mig-ERT2-infected cells.
(C) Activation of transcription factors. Ig
Pax5/ pro-B cells expressing BLNK-ERT2 or
ERT2 were incubated without ST2 cells and
IL-7 for 6 hr prior to OHT treatment and EMSA
analysis. A 100-fold excess of wild-type (W)
or mutant (M) oligonucleotides was used as
competitor DNA.
(D) Cell proliferation. A mixture of Ig
Pax5/ pro-B cells expressing the BLNK-
ERT2 (GFP) or ERT2 (hCD2) protein was cul-
tured in the presence of IL-7 and OHT (without
ST2 cells), and their proliferation was mea-
sured as change in cellular composition.
(E) IL-7 binding. Ig Pax5/ pro-B cells in-
fected with the Mig-BLNK-ERT2 virus were
treated with OHT for 48 hr prior to flow cyto-
metric analysis of IL-7R expression and IL-7
protein binding on infected GFP (green) and
noninfected GFP (black) cells.
in BLNK-ERT2-expressing cells, (2) no significant regula- of calcium signaling (Abrams et al., 1995), and the trans-
ferrin receptor-1 mediating iron uptake. Collectively,tion in the control GFP-expressing cells, and (3) no Pax5-
dependent repression in wild-type pro-B cells. In this these molecular data indicate that the pre-BCR exe-
cutes its checkpoint function by controlling genes in-manner, pre-BCR signaling was shown to activate 56
and to repress 34 genes, of which the majority corre- volved in cell proliferation, intracellular signaling, V(D)J
recombination, and growth factor responsiveness (Fig-sponds to unknown ESTs. The expression pattern of
selected genes was validated by RNase protection ure 7E).
assay (Figure 7C) and protein analyses (Figures 6E and
7D). The genes encoding the IL-7 receptorchain, cyclic Discussion
nucleotide phosphodiesterases (PDE) 2A and 4B, the
transmembrane protein NET6, and the transcription fac- The transcription factor Pax5 is essential for B-lineage
commitment and developmental progression beyond antor LEF1 were repressed upon pre-BCR signaling. Acti-
vated genes code for the transcriptional corepressor early pro-B cell stage (Nutt et al., 1997, 1999). Here
we have shown that Pax5 controls signaling from theSin3A, the transcription factors Id3 and c-Myc regulating
cell proliferation, the enzyme 3-OST modifying heparan (pre)BCR by directly regulating the expression of the
central adaptor protein BLNK. Restoration of BLNK ex-sulfate proteoglycans (Shwarok et al., 1997), the adaptor
protein RIADD coupling death proteases to signaling pression in Ig Pax5/ pro-B cells rescued the prolifer-
ative function of the pre-BCR but failed to promote dif-pathways (Duan and Dixit, 1997), pleckstrin-1 implicated
in cytoskeletal reorganization and negative regulation ferentiation to pre-B cells, which additionally depends
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Figure 7. Gene Expression Changes in Re-
sponse to Pre-BCR Signaling
(A) Repression of TdT and RAG genes. Ig
Pax5/ pro-B cells expressing BLNK-ERT2 or
ERT2 were incubated with OHT (1 M) for the
indicated hours prior to RNase protection
analysis.
(B) Expression screen. cDNA microarrays
containing 17,000 ESTs were hybridized with
Cy5- (red) and Cy3- (green) labeled cDNA
probes that were prepared before and after
OHT treatment of reconstituted Ig Pax5/
pro-B cells, respectively. Only genes that
were repeatedly induced (green) or repressed
(red) are included in the overview, which can
be accessed at http://www.immunity.org/cgi/
content/full/17/4/473/DC1 (Supplementary
Figure S3).
(C) Validation of microarray data. The expres-
sion of selected genes was analyzed by
RNase protection assay. 3-OST, heparan sul-
fate D-glucosaminyl 3-O-sulfotransferase;
TfR1, transferrin receptor-1; PDE, phospho-
diesterase; NET6, new EST tetraspan 6. The
EST BB277065 codes for a novel protein con-
taining a forkhead-associated (FHA) domain
and AK007503 for a protein with predicted
phospho-glucosidase activity.
(D) Western blot analysis of whole-cell extract
prepared from reconstituted Ig Pax5/
pro-B cells. All pro-B cells analyzed in (A)–(D)
were incubated with IL-7 in the absence of
ST2 cells for 48 hr, while OHT (1 M) was
added for the last hours indicated.
(E) Summary of expression changes. Synde-
can-4, SSeCKS, and INPP5B were identified
as pre-BCR-regulated genes by microarray
screen. SSeCKS is also known as gravin or
A kinase-anchoring protein 250 (Lin et al.,
2000). INPP5B, inositol polyphosphate 5-phos-
phatase II.
on Pax5 functions other than BLNK activation. The novel Pax5 for its expression in the B-lymphoid lineage. The
promoters of both genes contain, instead of a TATA-box,BLNK-ERT2 induction system facilitated conditional acti-
vation of pre-BCR signaling in Ig Pax5/ pro-B cells a high-affinity Pax5 binding site upstream of a cluster of
transcription start sites (Figure 1E; Kozmik et al., 1992).and thus provided insight into the transcriptional repro-
gramming at this developmental checkpoint. Pre-BCR Pax5 interacts with the TATA binding subunit of the
transcription factor TFIID (Eberhard and Busslinger,signaling was thus shown to regulate genes implicated
in intracellular signaling, cell proliferation, V(D)J recom- 1999) and may thus recruit the basal transcription ma-
chinery to the BLNK and CD19 promoters, which ex-bination, and growth factor responsiveness.
plains the strict dependency of both genes on this tran-
scription factor.Control of (Pre)BCR Signaling by Pax5
BLNK is the second known gene, in addition to CD19 The developmental arrest at the pre-BCR stage is
leaky in BLNK/ mice (Jumaa et al., 1999; Pappu et al.,(Nutt et al., 1997, 1998), that is entirely dependent on
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1999; Hayashi et al., 2000; Xu et al., 2000) in contrast protein ligase (Zheng et al., 2000), it is conceivable that
the Cbl-BLNK interaction targets the active signalingto the Pax5 mutant phenotype (Nutt et al., 1997). Consis-
tent with this difference, the restoration of BLNK expres- complex for ubiquitin-dependent degradation by the
proteasome, thus terminating the pre-BCR signal.sion in Ig Pax5/ pro-B cells rescued the proliferative
function but not the differentiation response of the pre-
BCR. In the absence of Pax5, the BLNK-reconstituted Function of the Pre-BCR
Ig Pax5/ pro-B cells retained their multilineage po- The transient expression of the pre-BCR on Ig pro-
tential, as they continued to express lineage-inappropri- B cells has so far prevented a detailed analysis of the
ate genes of other hematopoietic pathways and were gene expression changes elicited by pre-BCR activa-
able to differentiate into macrophages upon IL-7 with- tion. The use of the BLNK-ERT2 induction system in Ig
drawal (data not shown), similar to unmodified Pax5/ Pax5/ pro-B cells has now overcome this difficulty.
pro-B cells (Nutt et al., 1999). Hence, the developmental Microarray analyses using this cellular system pointed
progression to pre-B cells may require the repression to a crossregulation of the cAMP/PKA pathway by pre-
of lineage-promiscuous genes as well as the activation BCR signaling, which downregulates the expression of
of Pax5 target genes other than BLNK. the cAMP-degrading phosphodiesterases 2A and 4B
(Figure 7E). Pharmacological inhibitors of PDE activity
are known to increase the proliferation of human B cellsConstitutive Signaling of the Pre-BCR
BLNK expression in Ig Pax5/ pro-B cells was suffi- upon LPS/IL-4 stimulation (Gantner et al., 1998). In anal-
ogy, the pre-BCR-dependent decrease of PDE expres-cient to trigger constitutive signaling of the pre-BCR, as
evidenced by c-Kit and pre-BCR downregulation and sion may enhance the proliferation of pre-BCR pro-B
cells by increasing intracellular cAMP levels. On theincreased cell proliferation. Likewise, the mere activa-
tion of BLNK-ERT2 was sufficient to induce a rapid cal- other hand, the induction of INPP5B and pleckstrin-1
expression uncovered a regulatory feedback mecha-cium response and its associated gene expression
changes in Ig Pax5/ pro-B cells. In both cases, pre- nism that inhibits phosphoinositide-calcium signaling
(Figure 7E). The inositol polyphosphate 5-phosphatasesBCR signaling was activated even in the absence of
stromal cells that could otherwise present ligands to the (INPP5) hydrolize IP3 and thus function as calcium sig-
nal-terminating enzymes (Matzaris et al., 1998). Thepre-BCR. Our finding, that the pre-BCR constitutively
signals without stimulation, is in line with a recent report adaptor protein pleckstrin-1 binds to and stimulates the
activity of INPP5 enzymes upon phosphorylation by PKCthat pro-B cells do not require any cytokines or stromal
cells to proliferate and differentiate in a pre-BCR-depen- (Auethavekiat et al., 1997). The phosphorylated form
of pleckstrin-1 also interferes with the activity of PLCdent manner (Rolink et al., 2000). Moreover, a truncated
 chain that could no longer associate with surrogate proteins, thus preventing further generation of the cal-
cium signal IP3 (Abrams et al., 1995).light chains was still competent to activate pre-BCR
signaling in transgenic mice (Shaffer and Schlissel, The induction of c-myc and Id3 as well as the down-
regulation of SSeCKS expression provides molecular1997). A similar model of constitutive signaling has been
proposed for the related pre-TCR that colocalizes, in the evidence for the proliferative function of the pre-BCR, as
all three proteins are involved in controlling progressionabsence of ligation, with lipid rafts of early thymocytes
(Saint-Ruf et al., 2000) and even signals after deletion through the G1 phase of the cell cycle (Figure 7E). The
proliferation of B cells in response to BCR stimulationof its extracellular immunoglobulin domains (Irving et
al., 1998). Hence, the pre-BCR, like the pre-TCR, func- is severely impaired by inactivation of c-myc (de Alboran
et al., 2001) or Id3 (Pan et al., 1999). Pre-BCR signalingtions as a unique developmental checkpoint that con-
trols the productive outcome of a cell-autonomous leads to delayed induction of Id3, suggesting that this
gene is indirectly activated in pro-B cells as in TCR-rearrangement process without apparent need for extra-
cellular interactions. stimulated thymocytes (Bain et al., 2001). The cell cycle-
regulated scaffolding protein SSeCKS is known to bindThe human pre-BCR was shown to be associated with
a signaling complex consisting of phosphorylated Lyn, cyclin D in the cytoplasm and thus prevents the forma-
tion of nuclear cyclin D-CDK4 complexes that regulateSyk, Btk, PI3K, BLNK, Vav, and PLC2 proteins (Guo et
al., 2000). An essential function of this lipid raft-associ- G1-S progression by phosphorylating Rb (Lin et al.,
2000). Consequently, the reduced expression of thisated module is the BLNK-mediated phosphorylation of
PLC2 by Syk and Btk, which induces the phosphoinosi- negative mitogenic regulator contributes to the in-
creased cycling of pre-BCR pro-B cells, further indicat-tide-calcium signaling pathway (Guo et al., 2000; Kuro-
saki and Tsukada, 2000). Here we have shown that pre- ing that pre-BCR signaling regulates cell proliferation at
multiple levels.BCR-dependent calcium signaling rapidly activates the
transcription factor NF-	B, which may provide a selec- An important function of the pre-BCR is to signal allelic
exclusion at the IgH locus (Rajewsky, 1996), which istive survival signal for pro-B cells expressing a produc-
tively rearranged Ig gene analogous to its role in pre- initiated by transient repression of the V(D)J recombi-
nase genes RAG1 and RAG2 during the pro-B to pre-BTCR signaling (Voll et al., 2000). The Cbl protein is known
to suppress PLC2 activation by binding to phosphory- cell transition (Grawunder et al., 1995). Here we have
presented evidence for a direct involvement of pre-BCRlated BLNK in B cells (Yasuda et al., 2000). Interestingly,
the phosphorylated Syk, BLNK, and PLC2 proteins of signaling in the repression of the two RAG genes and
the terminal deoxynucleotidyl transferase (TdT) genethe pre-BCR signaling module were barely detectable
in continuously signaling, BLNK-reconstituted Ig (Figure 7E). The RAG2 protein accumulates only in G1,
as it is degraded during the S and G2/M phases inPax5/ pro-B cells. As Cbl can act as an E3 ubiquitin-
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siently transfected into human BJA-B cells, which were analyzedcycling cells due to phosphorylation by cyclinA/CDK2
by the Dual-Luciferase reporter assay (Promega).(Li et al., 1996). Pre-BCR signaling additionally induces
rapid degradation of the RAG1 protein (Figure 7D) and
S1 Nuclease and RNase Protection Assays
thus tightly regulates RAG expression both at the mRNA Total RNA of in vitro-cultured pro-B cells was analyzed by S1
and protein level. nuclease or RNase protection assay (Kozmik et al., 1992). Oligonu-
The pre-BCR transition coincides with a radical cleotide sequences used for RT-PCR cloning of the different ribo-
probes (Figure 7) can be found in Supplemental Table S1 at http://change in the growth factor requirements of B-lympho-
www.immunity.org/cgi/content/full/17/4/473/DC1).cytes. While pro-B cells require both IL-7 and stem cell
factor (Kit ligand) for their survival and proliferation (Ro-
Retroviral Infection of Pro-B Cellslink et al., 1991), the small pre-B cells become unrespon-
BLNK cDNAs were inserted into the retroviral vector MigR1 (Pear
sive to these growth factors due to loss of the corre- et al., 1998). The open reading frames of BLNK-GFP and BLNK-ERT2
sponding receptors (Rolink et al., 1994; Marshall et al., were fused by PCR cloning. The ERT2 cDNA (Feil et al., 1997) was
inserted into an MSCV vector containing an IRES-hCD2 minigene.1998). Here we have demonstrated that signaling from
Pro-B cells were cultured on ST2 cells in IL-7 medium and infectedthe pre-BCR is involved in the transcriptional repression
by coculture with GPE-86 packaging cells transfected with retrovi-of the IL-7R gene as well as in the posttranslational
ral constructs (Nutt et al., 1998).downregulation of cell surface c-Kit expression (Figure
7E). Pro-B cells also proliferate in response to Wnt sig- Antibodies and Flow Cytometry
nals due to the expression of LEF1, a nuclear mediator The anti-pre-BCR antibody SL156 (Winkler et al., 1995) was purified
of the Wnt/-catenin signaling pathway (Reya et al., and biotinylated. Anti-B220 (RA3-6B2), c-Kit (2B8), IL-7R (B12-1),
CD2 (RM2-5), CD19 (1D3), CD25 (7D4), and CD43 (S7) antibodies2000). The pre-BCR-dependent repression of LEF1 sug-
were obtained from PharMingen. IL-7 binding was determined bygests that the small pre-B cells also become refrac-
staining pro-B cells with biotinylated IL-7 protein (R&D Systems).tory to Wnt signals (Figure 7E). Growth factors like
Biotinylated proteins were revealed with APC-labeled streptavidin
IL-7 strictly depend on heparan sulfate proteoglycans (PharMingen).
(HSPG) for proper targeting to their high-affinity recep-
tors (Borghesi et al., 1999). The function of these core- Calcium Fluorimetry
Pro-B cells (2  106 ) were loaded with indo-1 acetoxymethylesterceptors can be influenced either by regulating their ex-
(5 M; Molecular Probes) in IL-7 medium (1 ml) at 37C for 45 minpression or by modulating the fine structure of their
followed by two washes and reincubation at 37C for 30 min. Theheparan sulfate moieties. Here we have provided evi-
fluorescence ratio of Indo-1 emission at 405/485 nm was measureddence for both mechanisms, which may account for the
in live cells on a BD-LSR flow-cytometer. Data acquisition was initi-
reduced IL-7 binding in response to pre-BCR signaling ated 50 s prior to addition of the anti- antibody M41.42 (10g/ml) or
(Figure 6E). As syndecan proteins are a major source of 4-hydroxy-tamoxifen (1 M; Research Biochemicals International).
cell surface heparan sulfate, it is likely that the repres-
Immunoprecipitation and Western Blottingsion of syndecan-4 reduces the heparan sulfate density
Pro-B cells were incubated for 4 hr without ST2 cells, IL-7, and fetalon pre-BCR pro-B cells (Figure 7E). Finally, pre-BCR
calf serum and then stimulated for 2 min at 37C with the anti-signaling leads to rapid expression of the enzyme
antibody M41.42 (10 g/ml) and pervanadate/H2O2 (50 M). Syk and3-OST, which modifies HSPGs by 3-O-sulfation and thus PLC2 were precipitated from whole-cell lysates with anti-Syk (C-20)
alters the growth factor binding specificity of these core- and anti-PLC2 (Q-20) antibodies (Santa Cruz) and BLNK by pull-
ceptors (Shwarok et al., 1997). down with a GST-Grb2(SH3-SH2) protein (Wienands et al., 1998).
Western blot analysis was performed with the following antibodies:
anti-tyrosine (4G10; Upstate Biotechnology), anti-BLNK (WienandsExperimental Procedures
et al., 1998), anti-Syk (N-19; Santa Cruz), anti-PLC2 (Transduction
Laboratories), anti-RAG1 (13781A; PharMingen), anti-RAG2 (432; S.More detailed methods can be found in the supplemental data at




Transgenic M54 and Pax5/ mice were described (Grosschedl et
Pro-B cells were incubated on ice with biotinylated SL156 antibody
al., 1984; Nutt et al., 1997). The IkBLNK transgene was generated by
and then with Alexa546-streptavidin (Molecular Probes). After fixa-
inserting BLNK cDNA (linked to IRES and GFP) into BAC 054C2
tion in 4% paraformaldehyde, cytospun cells were photographed
(Research Genetics) by recombination using 5 and 3 homology
using a Zeiss fluorescence microscope.
arms flanking Ik exon 1.
Microarray Analysis
BLNK cDNA and Promoter cDNA microarrays containing 5,500 IMAGE and 11,500 BMAP EST
BLNK cDNA was cloned from untreated and E2-stimulated (12 hr) clones (Research Genetics) were hybridized with Cy3- and Cy5-
KO-Pax5-ER cells using the PCR-Select cDNA Subtraction Kit (Clon- labeled cDNA probes, and the spot data were analyzed using the
tech). The BLNK promoter was subcloned by PCR from a 5 kb SacI GenePix program (Axon Inc). Figure 7B displays only genes that
fragment isolated from a mouse genomic library. The human BLNK showed1.5-fold repression or induction in two independent exper-
promoter (AF180740) was PCR cloned from genomic DNA. iments.
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